The Patent Finder
TB

Translate Bio, Inc.

First filing 2010
OverviewNotableFeesChangesFamiliesPatent listSources & methods

183 patents currently held

8 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

The next term ends in Dec 2030. from the record

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
1
Ending by 2030
Dec 2030
Next term end
79
Patent families

When these terms end

Held patents by the year their term ends
notable patents fee due within 90 days all others Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Dec 23, 2026
    The maintenance fee for mRNA FOR USE IN TREATMENT OF HUMAN GENETIC DISEASES (US 9,061,021) comes due Dec 23, 2026. Unpaid by Jun 23, 2027, it lapses early.
  • 2 fees due Jan 4 to 16, 2027 · next Jan 4
  • 2 fees due Feb 1 to 22, 2027 · next Feb 1
  • 2 fees due Mar 17 to 24, 2027 · next Mar 17
  • 2 fees due Apr 1 to 17, 2027 · next Apr 1
  • 3 fees due May 10 to 21, 2027 · next May 10
  • 4 fees due Jun 3 to 17, 2027 · next Jun 3
  • 1 fee due Jul 30, 2027
    The maintenance fee for Methods for Purification of Messenger RNA (US 11,884,692) comes due Jul 30, 2027. Unpaid by Jan 31, 2028, it lapses early.
  • 1 fee due Aug 6, 2027
    The maintenance fee for Lipid Formulations for Delivery of Messenger RNA (US 11,890,377) comes due Aug 6, 2027. Unpaid by Feb 7, 2028, it lapses early.
  • 3 fees due Sep 3 to 10, 2027 · next Sep 3
  • 7 fees due Oct 9 to 30, 2027 · next Oct 9
  • 3 fees due Nov 7 to 12, 2027 · next Nov 7

Which patents, and when each one lapses · Pro

Recent changes

What they patent

The 5 largest of its 79 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.

Patents held now

Soonest term end first.
PatentTitleStatusExpiresConfidence
US 10,576,166Liver Specific Delivery of Messenger RNA
In force
 · Medium confidence
In forceMedium confidence
US 8,853,377Mrna for Use in Treatment of Human Genetic Diseases
In force
 · High confidence
In forceHigh confidence
US 9,061,021mRNA FOR USE IN TREATMENT OF HUMAN GENETIC DISEASES
In force
 · Medium confidence
In forceMedium confidence
US 9,956,271mRNA FOR USE IN TREATMENT OF HUMAN GENETIC DISEASES
In force
 · High confidence
In forceHigh confidence
US 11,135,274mRNA FOR USE IN TREATMENT OF HUMAN GENETIC DISEASES
In force
 · Medium confidence
In forceMedium confidence
US 10,143,758Liver Specific Delivery of Messenger RNA
In force
 · Medium confidence
In forceMedium confidence
US 11,224,642Mrna Therapy for Argininosuccinate Synthetase Deficiency
In force
 · High confidence
In forceHigh confidence
US 9,308,281Mrna Therapy for Fabry Disease
In force
 · Low confidence
In forceLow confidence
US 9,597,413Pulmonary Delivery of Mrna
In force
 · Low confidence
In forceLow confidence
US 10,238,754Lipid Nanoparticle Compositions and Methods for Mrna Delivery
In force
 · Low confidence
In forceLow confidence
10 of 183 patents shown.
Pro members see all 183.
Pro members: see all 183 patents
Also on record, not counted in the 183: 8 patents in force now held by others · 67 applications pending · 47 applications abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited